Role of the Werner syndrome protein complex in the metabolism of chromosome ends
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
批准号:
8441584
负责人:
LUCIO COMAI
金额:
$34.7万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2015-03-31
关键词:
AffectAgeAge of OnsetAgingApoptosisArabidopsisBindingBiochemicalBiochemical GeneticsBiological AssayCardiovascular DiseasesCell AgingCell physiologyCellsChromosomesComplexDNADNA Binding DomainDNA DamageDNA StructureDataDevelopmentDiseaseDisease ProgressionDominant-Negative MutationEmployee StrikesEnzymesExcisionExonucleaseFamily memberFibroblastsFoundationsG22P1 geneGeneral PopulationGenesGeneticGenetic RecombinationGenomeGenomic InstabilityGoalsHereditary DiseaseHomeostasisHumanIn VitroIncidenceLengthLinkLongevityMaintenanceMalignant NeoplasmsMeasuresMediatingMetabolismModelingMolecularMolecular ConformationNamesNatureNormal CellNuclear ProteinNucleic AcidsPathologyPathway interactionsPatientsPhenotypePhysiologicalPlantsPlayPremature aging syndromeProcessProductionPropertyProteinsRegulationResidual stateRoleSignal TransductionSouthern BlottingTelomeraseTelomere MaintenanceTelomere ShorteningTestingTherapeutic AgentsTreatment EffectivenessTwo-Dimensional Gel ElectrophoresisWerner SyndromeWorkXRCC3 genebasechromatin immunoprecipitationearly onsetextrachromosomal DNAhelicasehomologous recombinationhuman WRN proteinimprovedin vivoinsightloss of function mutationmalignant phenotypemembermutantoverexpressionprematurepreventprotein complexprotein protein interactionpublic health relevancereconstitutionrepairedresearch studyresponsesenescencetelomeretherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The goal of this study is to gain mechanistic insights on the function of the Werner syndrome protein (WRN) complex in the processes that maintain telomere integrity and prevent the formation of extrachromosomal telomeric circles. WRN is a nuclear protein with helicase and exonuclease activities, whose loss-of-function mutations are associated with the premature aging and cancer prone disease Werner syndrome (WS). Genetic and biochemical evidence implicate WRN in telomere metabolism and suggest that abnormal telomere length homeostasis contributes to the pathology of WS. Our biochemical studies have shown that WRN operates as a functional unit with the Ku70/80 heterodimer and have further demonstrated that loss of WRN function causes the production of telomeric circles in fibroblasts expressing telomerase. To determine the mechanism whereby the WRN complex regulates telomere homeostasis, we propose to mechanistically characterize the functional interplay between WRN, Ku and telomere-specific factors found at chromosome ends and define the process activated by loss of WRN function responsible for the formation of telomeric circles. To accomplish these objectives we propose the following three aims. In Aim 1, we will characterize the role of WRN and its interacting partner Ku70/80 in the regulation of telomeric termini in human cells. In Aim 2, we will dissect the molecular mechanisms leading to the formation of extrachromosomal t- circles resulting from loss of WRN function. In Aim 3, we will characterize the biochemical properties of WRN in the context of model telomeric substrates in vitro. The studies proposed in this application will elucidate the role of WRN at telomeres and provide valuable information for understanding how loss of WRN function promotes genome instability, premature aging and the early onset of diseases such as cancer and cardiovascular disease. It is recognized that the incidence of these diseases increases progressively with age. Therefore, the changes at the molecular, cellular and physiologic levels that occur during aging profoundly influence the development and progression of these diseases. Functional analysis of WRN will provide a clearer understanding of these changes and will help in the development of therapeutic agents aimed at preventing the early onset of age-associated diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule therapeutics for myotonic dystrophy type 1
-
批准号:10583984
-
项目类别:
-
资助金额:$41.25万
-
财政年份:2023
-
负责人:LUCIO COMAI
-
依托单位:
Development and validation of a cell-based assay system to identify novel therapeutics for C9ALS/FTD
-
批准号:9978295
-
项目类别:
-
资助金额:$45.38万
-
财政年份:2020
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8695714
-
项目类别:
-
资助金额:$1.57万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8258211
-
项目类别:
-
资助金额:$24.48万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Identification of Therapeutic Small Molecules for Myotonic Dystrophy Type 1
-
批准号:8337720
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2011
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:8240043
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:7888108
-
项目类别:
-
资助金额:$38.01万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Role of the Werner syndrome protein complex in the metabolism of chromosome ends
-
批准号:8045351
-
项目类别:
-
资助金额:$37.28万
-
财政年份:2010
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7735572
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7352997
-
项目类别:
-
资助金额:$47.97万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7564050
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7989418
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:8197219
-
项目类别:
-
资助金额:$49.82万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
Biochemical analyses of muscleblind complexes in myotonic dystrophy
-
批准号:7869533
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2007
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:7447381
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:7243372
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:7069615
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:6897435
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
The Werner syndrome protein in CPT-induced DNA damage
-
批准号:6768943
-
项目类别:
-
资助金额:$31.84万
-
财政年份:2004
-
负责人:LUCIO COMAI
-
依托单位:
VIRAL REGULATION OF RIBOSOMAL RNA TRANSCRIPTION
-
批准号:6490095
-
项目类别:
-
资助金额:$16.68万
-
财政年份:1998
-
负责人:LUCIO COMAI
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: